Published in Diabetologia on July 16, 2005
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. Eur Heart J (2010) 2.68
Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis. Pharmacoepidemiol Drug Saf (2009) 1.18
Rosiglitazone RECORD study: glucose control outcomes at 18 months. Diabet Med (2007) 1.08
Rosiglitazone is associated with mortality in chronic hemodialysis patients. J Am Soc Nephrol (2009) 1.05
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study). Cardiovasc Diabetol (2008) 0.99
Transcriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-gamma: Therapeutic Implications for Cardiovascular Diseases. PPAR Res (2008) 0.88
Thiazolidinedione treatment and constitutive-PPARgamma activation induces ectopic adipogenesis and promotes age-related thymic involution. Aging Cell (2010) 0.87
Antidiabetic agents and cardiovascular risk in type 2 diabetes. Nat Rev Endocrinol (2009) 0.86
Effects of rosiglitazone on the configuration of action potentials and ion currents in canine ventricular cells. Br J Pharmacol (2011) 0.84
Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study. Diabetes Care (2011) 0.83
PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study. Vasc Health Risk Manag (2007) 0.83
Should We Use PPAR Agonists to Reduce Cardiovascular Risk? PPAR Res (2008) 0.80
Early vascular aging (EVA): consequences and prevention. Vasc Health Risk Manag (2008) 0.80
Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action. Pharmaceuticals (Basel) (2010) 0.79
Peroxisome proliferator-activated receptor agonists: do they increase cardiovascular risk? PPAR Res (2009) 0.76
Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters. Clin Med Insights Cardiol (2011) 0.75
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics (1975) 18.25
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32
British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J (Clin Res Ed) (1981) 14.25
Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) (1983) 10.90
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med (2001) 10.36
Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet (2000) 9.80
Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med (1987) 8.64
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med (1992) 7.33
British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality. Br Med J (1980) 5.56
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br Med J (1980) 4.97
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med (1998) 4.68
Randomized trials or observational tribulations? N Engl J Med (2000) 4.49
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. Diabetologia (2010) 4.33
Function of an ophthalmic "accident and emergency" department: results of a six month survey. Br Med J (Clin Res Ed) (1986) 4.11
The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J (2003) 4.09
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J (Clin Res Ed) (1986) 3.76
Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance--a population-based twin study. Diabetologia (1999) 3.64
Can meta-analyses be trusted? Lancet (1991) 3.43
Long-term survival of patients with breast cancer: a study of the curability of the disease. Br Med J (1979) 3.29
Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ (2001) 3.12
An epidemiological study of workers producing enzyme washing powders. Lancet (1970) 2.98
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus. Diabetologia (2006) 2.82
The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J (2003) 2.78
Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J (2004) 2.73
Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination. Br Med J (1980) 2.71
Frosted branch angiitis: a review. Eye (Lond) (2004) 2.66
Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care (2000) 2.59
A scoring system to identify men at high risk of a heart attack. Health Trends (1987) 2.58
Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet (1995) 2.52
Risk factors for stroke in middle aged British men. BMJ (1991) 2.44
The epidemic of type 2 diabetes is a statistical artefact. Diabetologia (2005) 2.41
Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia (1997) 2.41
Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ (1995) 2.40
Lead exposure and children's intellectual performance. Int J Epidemiol (1987) 2.30
Regression of area mortality rates on explanatory variables: what weighting is appropriate? J R Stat Soc Ser C Appl Stat (1981) 2.26
Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J (1999) 2.24
Myocardial ischaemia in patients with frequent angina pectoris. Br Med J (1978) 2.22
Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes. Diabetes Obes Metab (2006) 2.21
Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. Eur Heart J (1998) 2.20
Giving up smoking and the risk of heart attacks. A report from The British Regional Heart Study. Lancet (1986) 2.19
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15
Allocation of patients to treatment in clinical trials. Biometrics (1979) 2.13
On the design and analysis of randomized clinical trials with multiple endpoints. Biometrics (1993) 2.13
Uveitis and the menstrual cycle. Eye (Lond) (2004) 2.10
Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation (1998) 2.04
Nimesulide-induced hepatitis and toxic epidermal necrolysis. J Postgrad Med (2008) 2.03
Short-term effects of air pollution on daily mortality in Athens: a time-series analysis. Int J Epidemiol (1994) 2.03
Effects of alcohol and smoking on blood lead in middle-aged British men. Br Med J (Clin Res Ed) (1982) 2.03
The combination of randomized and historical controls in clinical trials. J Chronic Dis (1976) 2.00
Waiting times and the patient's charter. BMJ (1994) 1.99
Issues in data monitoring and interim analysis of trials. Health Technol Assess (2005) 1.96
Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.96
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet (1998) 1.94
Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest (1990) 1.94
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia (2011) 1.94
Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia (2002) 1.93
Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis (1992) 1.89
Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med (2006) 1.84
Biochemical and haematological response to alcohol intake. Ann Clin Biochem (1985) 1.84
Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure. Am J Med (1984) 1.83
British blood cholesterol values and the American consensus. Br Med J (Clin Res Ed) (1985) 1.80
NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland. Heart (2007) 1.80
Blood pressure and hypertension in middle-aged British men. J Hypertens (1988) 1.80
Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes. Eur Heart J (1998) 1.79
Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study. BMJ (1991) 1.79
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet (1994) 1.78
Retrospective study of influence of deprivation on uptake of cardiac rehabilitation. BMJ (1996) 1.76
Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial. Eur Heart J (2004) 1.74
Management of patients with heart failure in clinical practice: differences between men and women. Heart (2007) 1.73
High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. Br Med J (Clin Res Ed) (1986) 1.73
Commuter travel and sickness absence of London office workers. Br J Prev Soc Med (1972) 1.72
Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart (1997) 1.72
Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy. Eur Heart J (2000) 1.68
Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism (2002) 1.68
Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia (2001) 1.65
Optic disc in fundus coloboma. Ophthalmology (1996) 1.65
Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation (2001) 1.64
Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia (2010) 1.64
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia (1995) 1.63
Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol (1994) 1.60
Blood lead concentration, blood pressure, and renal function. Br Med J (Clin Res Ed) (1984) 1.60
Stopping rules and estimation problems in clinical trials. Stat Med (1988) 1.58
Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. Lancet (2001) 1.58
[Adherence to guidelines in CHF therapy in Germany]. Dtsch Med Wochenschr (2005) 1.58
Ethnic differences in certified sickness absence. Br J Ind Med (1982) 1.57
Impaired insulin-induced site-specific phosphorylation of TBC1 domain family, member 4 (TBC1D4) in skeletal muscle of type 2 diabetes patients is restored by endurance exercise-training. Diabetologia (2010) 1.57
Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data. Diabetologia (2004) 1.57
Interim analyses for randomized clinical trials: the group sequential approach. Biometrics (1982) 1.57
Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism. J Clin Invest (1987) 1.56
Differences in physical characteristics, perinatal histories, and social backgrounds between children with growth hormone deficiency and constitutional short stature. Arch Dis Child (1981) 1.56
Ocular syphilis: the new epidemic. Eye (Lond) (2005) 1.56